Indium Phosphide Drives AXT’s Revenue to Three-Year High, Gross Margin Rebounds Sharply in Q3


Re-Tweet
Share on LinkedIn

Indium Phosphide Demand Fuels Strong Turnaround for AXT in Q3 2025

Record Indium Phosphide Sales and Export Permits Mark a New High

AXT, Inc. has posted a strong third quarter, reporting that indium phosphide revenues surged over 250% sequentially to a three-year high, as export permits cleared the way for large shipments tied to data center upgrades. According to CEO Morris Young, "the strong uptick in indium phosphide demand from data center applications globally" and continued healthy backlog in both indium phosphide and gallium arsenide products underpin this momentum.

Revenue and Gross Margin Show Dramatic Sequential Improvement

Q3 revenue came in at $28.0 million, up sharply from $18.0 million in Q2 and higher than the $23.6 million posted a year earlier. Gross margin more than doubled sequentially—rebounding from 8.0% in Q2 to 22.3% in Q3 (non-GAAP: 22.4%), although still slightly below last year's 24% margin. The company points to discipline in expense management and a focus on inventory reduction as part of its recovery efforts.

Q3 2025 Q2 2025 Q3 2024
Revenue: $27.96M $18.00M $23.65M
GAAP Gross Margin: 22.3% 8.0% 24.0%
Non-GAAP Gross Margin: 22.4% 8.2% 24.3%
GAAP Net Loss: -$1.91M - $7.00M - $2.94M
Non-GAAP Net Loss: -$1.17M - $6.40M - $2.12M

Profitability Metrics Trend in the Right Direction

The quarter’s net loss narrowed substantially to $1.91 million GAAP ($0.04 per share) from $7.0 million in Q2. Non-GAAP net loss also shrank meaningfully. This progress reflects better product mix, margin expansion, and operational improvements—even as research and development costs declined sharply from a year ago.

Balance Sheet and Operating Highlights Support Stability

Cash and cash equivalents were steady at $23.11 million. Inventories decreased from $85.08 million at the start of the year to $77.66 million, supporting the management's focus on working capital efficiency. Total assets stand at $334.03 million versus $339.31 million at year-end 2024, indicating disciplined asset management despite top-line growth.

Key Balance Sheet Metrics (Q3 2025) Amount
Cash & Equivalents $23.11M
Accounts Receivable $33.84M
Inventories $77.66M
Total Assets $334.03M

IPO Update: STAR Market Path Still Ongoing for Tongmei

On the corporate development front, AXT’s Beijing subsidiary Tongmei continues to advance toward a public listing on China’s STAR Market, having received regulatory review acceptance from the Shanghai Stock Exchange and China Securities Regulatory Commission. The company notes that the IPO process remains subject to further review and could represent a major strategic milestone once completed.

Looking Ahead: Recovery and Data Center Demand Offer Room for Growth

Management’s tone is decidedly optimistic: "We believe we have tremendous opportunity in 2026 to drive meaningful growth in our business and a return to profitability," citing sustained demand from data centers and ongoing recovery in core markets. While geopolitical and regulatory headwinds remain, current trends point to an improving fundamental outlook for AXT, especially as the next data center upgrade cycle unfolds.

Takeaway for Investors

AXT’s Q3 shows how quickly demand shifts in advanced materials can reset a company’s fortunes, especially in semiconductor-linked industries. The dramatic turnaround in indium phosphide revenues, margin recovery, and shrinking losses signal that the company’s efforts to adapt to market trends are bearing fruit. For those tracking compound semiconductor suppliers or data center buildouts, AXT’s path into 2026 merits close attention as a potential inflection point for renewed profitability and strategic execution.


Contact Information:

If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.


About the Publisher - Marketchameleon.com:

Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.


NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.


The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.


Disclosure: This article was generated with the assistance of AI

Market Data Delayed 15 Minutes